Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

29.06.17	Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone's proprietary Pulsar™ Advanced Intrathecal Precision Delivery Platform Technology for use in Gene... (PR Newswire)
29.06.17	Biotech Stocks Facing FDA Decision In July (RTTNews)
26.06.17	Breakfast Technical Briefing on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson (PR Newswire)
21.06.17	S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017 (PR Newswire)
16.06.17	Pfizer Reports Overall Efficacy In Xeljanz Oral Safety Study (RTTNews)
15.06.17	ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar (RTTNews)
14.06.17	Patented Biotechnology Formulations Resulting in New Generation of Animal Healthcare Medications and Treatments (PR Newswire)
14.06.17	Patented Biotechnology Formulations Resulting in New Generation of Animal Healthcare Medications and Treatments (PR Newswire)
13.06.17	Pfizer And Lilly Gets FDA Fast Track Designation For Tanezumab (RTTNews)
12.06.17	LXRX Brings Sweet Tidings, PFE's PROSPER Ahead Of Schedule, XBIT Fails To Excite (RTTNews)
07.06.17	Sangamo: SB-525 Therapy Receives Orphan Medicinal Product Designation From EMA (RTTNews)
07.06.17	Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency (PR Newswire)
06.06.17	Pfizer Gets FDA Fast Track Designation For Tafamidis For TTR-CM (RTTNews)
05.06.17	AMGN Finds New Use For Old Drug, NLNK Disappointed, ECYT Cuts Workforce (RTTNews)
02.06.17	GSK Reports EU & US Submissions For First HIV Maintenance Regimen - Quick Facts (RTTNews)
30.05.17	Pfizer: EC Oks TRUMENBA For Prevention Of Invasive Meningococcal Disease (RTTNews)
26.05.17	FDA Panel Recommends Approval Of Epoetin Alfa Biosimilar Across All Indications (RTTNews)
25.05.17	How These Healthcare Stocks are Faring? -- Pfizer, Zoetis, Mallinckrodt, and Patheon (PR Newswire)
24.05.17	Pfizer Recommends Stockholders To Reject TRC Capital's Mini-tender Offer (RTTNews)
22.05.17	Investors: Option reports for Citigroup, The Gap, Nike, NVIDIA and Pfizer Inc. include trade ideas that offer returns of 18% or more! (PR Newswire)
19.05.17	Company Spotlight: GlycoMimetics (RTTNews)
18.05.17	The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis (PR Newswire)
18.05.17	The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis (PR Newswire)
18.05.17	Astellas Announces Oncology Portfolio Updates (PR Newswire)
16.05.17	Pfizer Posting Notable Loss After Downgrade By Citi (RTTNews)
16.05.17	Sangamo Gets Fast Track Designation For SB-525 Hemophilia A Gene Therapy (RTTNews)
11.05.17	Covered Call reports for Apple, Coty Inc., NVIDIA, Pfizer Inc. and Yelp include trade ideas that offer returns of 21% or more! (PR Newswire)
10.05.17	Sangamo Therapeutics And Pfizer Announce Collaboration For Hemophilia A Gene Therapy (PR Newswire)
09.05.17	FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer (PR Newswire)
09.05.17	FDA Grants BAVENCIO® (avelumab) Approval for a Common Type of Advanced Bladder Cancer (PR Newswire)
04.05.17	BPMX Craters, KPTI Surges On Deal With Anivive, PFE Seeks New Use For Old Drug (RTTNews)
02.05.17	Investors: Covered Call reports for Exelixis, Facebook, Priceline, Pfizer Inc. and AT&T include trade ideas that offer returns of 18% or more! (PR Newswire)
02.05.17	Pfizer Q1 Profit Beats Estimates, Revenues Up 1% Excl. HIS; Reaffirms Guidance (RTTNews)
02.05.17	Pfizer Inc. Q1 Income Advances 0% (RTTNews)
25.04.17	Ellington Residential Mortgage REIT Announces Release Date of First Quarter 2017 Earnings, Conference Call, and Investor Presentation (PR Newswire)
25.04.17	Aquinnah Pharmaceuticals Receives $10 Million Investment from Pfizer and AbbVie to Research Breakthrough Approach to Neurodegenerative Disease (PR Newswire)
24.04.17	Pfizer Announces Positive Results Of REPROVE Study (RTTNews)
22.04.17	Hospira Recalls One Lot Of 25% Dextrose Injection, USP (Infant) (RTTNews)
20.04.17	Pfizer Gets US DoJ Subpoena In Intravenous Saline Investigation (RTTNews)
18.04.17	5 Stocks to Watch as Canada Gets Hooked on Cannabis (PR Newswire)
18.04.17	HitGen, Pfizer Enter Research Collaboration & License Agreement - Quick Facts (RTTNews)
10.04.17	Drug Makers Stocks on Investors' Radar -- Pfizer, Merck, Johnson & Johnson, and AbbVie (PR Newswire)
06.04.17	Global Oncology Market Gains Ground, Driven by Innovative Cancer Treatment Therapies (PR Newswire)
27.03.17	Pfizer: XELJANZ In Combination With Methotrexate Gets EC Approval For RA (RTTNews)
27.03.17	XENE Loses Face As Acne Trial Flops, NBRV Awaits LEAP Data, Opdivo Scores A Nod (RTTNews)
24.03.17	Pfizer Gets Positive CHMP Opinion For TRUMENBA (RTTNews)
24.03.17	Biotech Stocks Facing FDA Decision In April (RTTNews)
24.03.17	FDA Approves First-ever Merkel Cell Carcinoma Drug, HTGM Riding High, FLXN Soars (RTTNews)
23.03.17	FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma (PR Newswire)
23.03.17	FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
22.11.24		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
22.11.24		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Handel in Frankfurt: TecDAX letztendlich in Grün
22.11.24		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

22.11.24

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

22.11.24

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Handel in Frankfurt: TecDAX letztendlich in Grün